BIOMAT Database Logo BIOMAT Database Logo

Primary cutaneous γδ T-cell lymphoma following mycosis fungoides. 2014

Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D009182 Mycosis Fungoides A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016410 Lymphoma, T-Cell, Cutaneous A group of lymphomas exhibiting clonal expansion of malignant T-lymphocytes arrested at varying stages of differentiation as well as malignant infiltration of the skin. MYCOSIS FUNGOIDES; SEZARY SYNDROME; LYMPHOMATOID PAPULOSIS; and PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA are the best characterized of these disorders. Granulomatous Slack Skin,T-Cell Lymphoma, Cutaneous,Cutaneous T-Cell Lymphoma,Lymphoma, T Cell, Cutaneous,Cutaneous T Cell Lymphoma,Cutaneous T-Cell Lymphomas,Lymphoma, Cutaneous T-Cell,Lymphomas, Cutaneous T-Cell,Slack Skin, Granulomatous,T Cell Lymphoma, Cutaneous,T-Cell Lymphomas, Cutaneous
D016609 Neoplasms, Second Primary Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause. Neoplasms, Metachronous,Neoplasms, Metachronous Second Primary,Neoplasms, Therapy-Related,Neoplasms, Treatment-Related,Second Malignancy,Second Neoplasm,Second Primary Neoplasms,Therapy-Associated Neoplasms,Therapy-Related Cancer,Treatment-Associated Neoplasms,Treatment-Related Cancer,Cancer, Second Primary,Metachronous Neoplasms,Metachronous Second Primary Neoplasms,Neoplasms, Therapy-Associated,Neoplasms, Treatment-Associated,Second Cancer,Second Primary Neoplasms, Metachronous,Therapy-Associated Cancer,Therapy-Related Neoplasms,Treatment-Associated Cancer,Treatment-Related Neoplasms,Cancer, Second,Cancer, Therapy-Associated,Cancer, Therapy-Related,Cancer, Treatment-Associated,Cancer, Treatment-Related,Cancers, Second,Cancers, Second Primary,Cancers, Therapy-Associated,Cancers, Therapy-Related,Cancers, Treatment-Associated,Cancers, Treatment-Related,Malignancies, Second,Malignancy, Second,Metachronous Neoplasm,Neoplasm, Metachronous,Neoplasm, Second,Neoplasm, Second Primary,Neoplasm, Therapy-Associated,Neoplasm, Therapy-Related,Neoplasm, Treatment-Associated,Neoplasm, Treatment-Related,Neoplasms, Second,Neoplasms, Therapy Associated,Neoplasms, Therapy Related,Neoplasms, Treatment Associated,Neoplasms, Treatment Related,Second Cancers,Second Malignancies,Second Neoplasms,Second Primary Cancer,Second Primary Cancers,Second Primary Neoplasm,Therapy Associated Cancer,Therapy Associated Neoplasms,Therapy Related Cancer,Therapy Related Neoplasms,Therapy-Associated Cancers,Therapy-Associated Neoplasm,Therapy-Related Cancers,Therapy-Related Neoplasm,Treatment Associated Cancer,Treatment Associated Neoplasms,Treatment Related Cancer,Treatment Related Neoplasms,Treatment-Associated Cancers,Treatment-Associated Neoplasm,Treatment-Related Cancers,Treatment-Related Neoplasm
D016692 Receptors, Antigen, T-Cell, gamma-delta T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see ANTIGENS, CD3). Antigen Receptors, T-Cell, gamma-delta,T-Cell Receptors delta-Chain,T-Cell Receptors gamma-Chain,T-Cell Receptors, gamma-delta,TcR gamma-delta,Antigen T Cell Receptor, delta Chain,Antigen T Cell Receptor, gamma Chain,Receptors, Antigen, T Cell, gamma delta,T Cell Receptors, gamma delta,T-Cell Receptor delta-Chain,T-Cell Receptor gamma-Chain,T-Cell Receptor, gamma-delta,T Cell Receptor delta Chain,T Cell Receptor gamma Chain,T Cell Receptor, gamma delta,T Cell Receptors delta Chain,T Cell Receptors gamma Chain,TcR gamma delta,delta-Chain, T-Cell Receptor,delta-Chain, T-Cell Receptors,gamma-Chain, T-Cell Receptor,gamma-Chain, T-Cell Receptors,gamma-delta T-Cell Receptor,gamma-delta T-Cell Receptors,gamma-delta, TcR

Related Publications

Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Cutaneous T-cell lymphoma (mycosis fungoides)
March 1996, Lancet (London, England),
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Mycosis fungoides: cutaneous T cell lymphoma.
April 1986, Indiana medicine : the journal of the Indiana State Medical Association,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Cutaneous T-Cell Lymphoma (Mycosis Fungoides).
April 2007, Medical journal, Armed Forces India,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Cutaneous T-cell lymphoma (mycosis fungoides)
July 1996, Lancet (London, England),
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Mycosis fungoides: cutaneous T-cell lymphoma.
May 1991, American family physician,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
[CUTANEOUS T CELL LYMPHOMA: UNILESIONAL MYCOSIS FUNGOIDES].
October 2016, Harefuah,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
[Primary cutaneous lymphoma--mycosis fungoides].
January 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Treatment of cutaneous T-cell lymphoma/mycosis fungoides.
December 2006, Dermatology nursing,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Cutaneous T cell lymphoma (mycosis fungoides) in blacks.
September 1981, Journal of the National Medical Association,
Hiraku Suga, and Makoto Sugaya, and Tomomitsu Miyagaki, and Hanako Ohmatsu, and Hideki Fujita, and Shinichi Sato
Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides).
February 1987, Archives of dermatology,
Copied contents to your clipboard!